Leukemia

Showing NaN - NaN of 86

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

    Active, not recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Jul 20, 2022

    Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

    Recruiting
    • Chronic Graft-versus-Host-Disease
    • +4 more
      • San Francisco, California
      • +15 more
      Jun 17, 2022

      Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

      Recruiting
      • Pancreatic Cancer
      • +49 more
        • Colorado Springs, Colorado
        • +80 more
        Feb 22, 2022

        Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

        Active, not recruiting
        • Leukemia
        • Birmingham, Alabama
        • +184 more
        Feb 4, 2022

        Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

        Completed
        • Leukemia
        • Birmingham, Alabama
        • +197 more
        Mar 22, 2021

        Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)

        Terminated
        • Leukemia
        • rituximab
        • fludarabine phosphate
        • Anniston, Alabama
        • +386 more
        Apr 9, 2020

        Leukemia, Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

        Terminated
        • Leukemia
        • Lymphoma
        • therapeutic allogeneic lymphocytes
        • +8 more
        • Denver, Colorado
        • +22 more
        Apr 8, 2020

        Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

        Completed
        • Leukemia
        • +4 more
        • therapeutic allogeneic lymphocytes
        • +6 more
        • Denver, Colorado
        • +13 more
        Sep 13, 2019

        Leukemia Trial in Worldwide (Midostaurin (PKC412))

        Completed
        • Leukemia
        • Midostaurin (PKC412)
        • Los Angeles, California
        • +28 more
        Oct 16, 2018

        Cell Damage in Acute Myeloid Leukemia, Myelodysplastic

        Completed
        • Leukemia
        • Myelodysplastic Syndromes
        • cytogenetic analysis
        • +3 more
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Nov 30, 2017

        Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic

        Completed
        • Leukemia
        • +2 more
        • Allogeneic bone marrow transplantation
        • Peripheral blood stem cell transplantation
        • Birmingham, Alabama
        • +44 more
        Oct 24, 2017

        Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)

        Terminated
        • Chronic Myeloproliferative Disorders
        • +6 more
        • anti-thymocyte globulin
        • +16 more
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Sep 25, 2017

        Leukemia Trial in Portland (drug, radiation, other)

        Terminated
        • Leukemia
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Sep 25, 2017

        Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)

        Completed
        • Chronic Myeloproliferative Disorders
        • +6 more
        • therapeutic allogeneic lymphocytes
        • +9 more
        • Portland, Oregon
          Knight Cancer Institute at Oregon Health and Science University
        Sep 25, 2017

        Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )

        Completed
        • Chronic Myeloproliferative Disorders
        • +9 more
        • baclofen/amitriptyline/ketamine gel
        • placebo
        • Scottsdale, Arizona
        • +164 more
        Jul 25, 2017

        Leukemia Trial in Canada, United States (clofarabine, cytarabine, methotrexate)

        Completed
        • Leukemia
        • Birmingham, Alabama
        • +78 more
        May 3, 2017

        Blood Samples From Patients onClinical Trial to CINV During HSCT

        Terminated
        • Breast Cancer
        • +11 more
        • immunoenzyme technique
        • +2 more
        • Portland, Oregon
          OHSU Knight Cancer Institute
        May 7, 2017

        Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Portland (moxifloxacin HCl, Placebo)

        Terminated
        • Breast Cancer
        • +11 more
        • moxifloxacin hydrochloride
        • Placebo
        • Portland, Oregon
          Knight Cancer Institute at Oregon Health and Science University
        May 7, 2017

        Leukemia Trial in Worldwide (biological, drug, radiation)

        Completed
        • Leukemia
        • filgrastim
        • +12 more
        • Birmingham, Alabama
        • +152 more
        Feb 14, 2017

        Leukemia Trial in United States (cytarabine, idarubicin, lestaurtinib)

        Completed
        • Leukemia
        • Birmingham, Alabama
        • +20 more
        Feb 7, 2017